Evidence map›Paper›PMID 39170726›Full record

ArticleVirus evolution2024

Opening a 60-year time capsule: sequences of historical poliovirus cold variants shed a new light on a contemporary strain.

Morgane Chesnais, Erika Bujaki, Typhaine Filhol, Vincent Caval, Marie-Line Joffret, Javier Martin, Nolwenn Jouvenet, Maël Bessaud

Abstract read
In one paragraph

Article in Virus evolution, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Morgane ChesnaisInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.
Erika BujakiDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom.
Typhaine FilholInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.
Vincent CavalInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.
Marie-Line JoffretInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.ORCID https://orcid.org/0000-0002-5244-5429
Javier MartinDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom.
Nolwenn JouvenetInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.
Maël BessaudInstitut Pasteur, Université de Paris Cité, CNRS UMR 3569, Virus sensing and signaling Unit, 28 rue du Dr Roux, Paris 75 015, France.ORCID https://orcid.org/0000-0001-6758-9591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polioviruses (PVs) are positive strand RNA viruses responsible for poliomyelitis. Many PVs have been isolated and phenotypically characterized in the 1940s-50s for the purpose of identifying attenuated strains that could be used as vaccine strains. Among these historical PVs, only few are genetically characterized. We report here the sequencing of four PV strains stored for more than 60 years in a sealed box. These PVs are cold variants that were selected by Albert Sabin based on their capacity to multiply at relatively low temperatures. Inoculation of permissive cells at 25°C showed that two of the four historical virus stocks still contained infectious particles. Both viruses reached titres that were higher at 25°C than at 37°C, thus demonstrating that they were genuine cold variants. We obtained sequences that span virtually all the genome for three out of the four strains; a short sequence that partly covers the 5' untranslated region was recovered for the last one. Unexpectedly, the genome of one historical cold variant (which derives from PV-3 Glenn) displayed a very high nucleotide identity (above 95%) with that of a PV strain (PV-3 strain WIV14) sampled in China in 2014 and then classified as a highly evolved vaccine-derived PV. Our analyses made this hypothesis very unlikely and strongly suggested that Glenn and WIV14 shared a very recent common ancestor with one another. Some strains used to produce the inactivated polio vaccine were also very close to Glenn and WIV14 in the capsid-encoding region, but they had not been sequenced beyond the capsid. We therefore sequenced one of these strains, Saukett A, which was available in our collection. Saukett A and WIV14 featured an identity higher than 99% at the nucleotide level. This work provides original data on cold variants that were produced and studied decades ago. It also highlights that sequences of historical PV strains could be crucial to reliably characterize contemporary PVs in case of release from a natural reservoir or from a facility, which is of highest importance for the PV eradication program.

Indexed as

cold mutantscold variantscontainmententeroviruspoliovirusesSaukettvaccine-derived polioviruses

Identifiers

PMID39170726
PMCPMC11336667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.